Position in MRK
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$13,357,832
+$504,966 QoQ
Shares Held
103,952
-2.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
#640
of 3,768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JACOBS & CO/CA holds $94,475,102 across 9 Drug Manufacturers - General names. MRK ranks #4 (14.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,017 | $34,803,863 | |
| 2 | ABBV |
AbbVie Inc.
|
61,621 | $15,506,308 | |
| 3 | AMGN |
Amgen Inc
|
42,343 | $15,333,247 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
103,952 | $13,357,832 | |
| 5 | JNJ |
Johnson & Johnson
|
48,675 | $12,361,989 | |
| 6 | PFE |
Pfizer Inc
|
82,804 | $1,993,920 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,090 | $516,730 | |
| 8 | NVS |
Novartis AG
|
2,520 | $394,934 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,357,832 | 103,952 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $12,852,866 | 106,849 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $11,480,602 | 109,069 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $9,173,381 | 109,298 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $8,787,314 | 111,007 | Shares | Sole | 2025-07-02 | |
| 2025-03-31 | $10,253,284 | 114,230 | Shares | Sole | 2025-04-03 | |
| 2024-12-31 | $11,305,006 | 113,641 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $12,365,548 | 108,890 | Shares | Sole | 2024-10-01 | |
| 2024-06-30 | $12,687,395 | 102,483 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $13,615,920 | 103,190 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $11,591,333 | 106,323 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $10,423,893 | 101,252 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $11,533,692 | 99,954 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $11,275,212 | 105,980 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $12,638,092 | 113,908 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $11,015,609 | 127,910 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $11,798,127 | 129,408 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $11,494,302 | 140,089 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $10,882,880 | 142,000 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $10,333,333 | 137,576 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $10,022,530 | 128,874 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $8,730,986 | 113,257 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $8,429,731 | 103,053 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $7,692,371 | 92,735 | Shares | Sole | 2020-12-03 | |
| 2020-06-30 | $6,759,804 | 87,415 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $6,026,784 | 78,331 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||